NeuroXess raises RMB 700M Series B for brain-computer interface
10/28/2026 — 10/28, 12:18·3 sources (all)·4 reports (all)
Key takeaways
- NeuroXess announced a RMB 700 million Series B round led by State Development & Investment Corp., Shenzhen Capital Group and Qinzhi Capital,…
Background & analysis
On the morning of October 28, 2026, China-based brain-computer interface company NeuroXess announced the completion of a 700 million CNY Series B financing round. The round was co-led by SDIC Jurong, Shenzhen Capital Group and Qinzhi Capital, with follow-on participation from a group of investors including SMIC Capital, Huangpu Investment, Cornerstone Capital, IDG Capital, Xichen Capital, Junrui Capital, Huafu Securities, Huasai Zhihui, Zhongwei Capital and Jiangxi FinHold, while Shengdong and Zhongping Capital continued their support.
Founded in 2021, NeuroXess develops implantable flexible brain-computer interface systems. According to the company, the funding will be directed at four priorities: multi-center registrational clinical trials and regulatory approval for its fully implantable, fully wireless and fully functional "Three-Complete" system; construction of a mass-production "super factory"; development of next-generation products; and continued work on BCI+AI integration. Next-generation research is said to focus on iterating and optimizing language BCI while accelerating visual BCI development, while the BCI+AI work will target invoking AI through intent, connecting tools and driving environments, with the goal of building BCI+AI models for the physical world and collecting brain activity data in real scenarios. The company aims to achieve large-scale commercial deployment in the medical market within two years.
A Wall Street Journal report on the same day added that NeuroXess has begun building a super factory with a planned area of 14,300 square meters and a target capacity on the scale of 10,000 units per year. The company disclosed that it has completed a cumulative total of 65 clinical trials, and that in July of this year the Three-Complete system began GCP registrational clinical trials at Huashan Hospital affiliated with Fudan University, led by Professor Mao Ying's team in cooperation with multiple tertiary hospitals across the country. The company's clinical progress and mass-production plans remain subject to its subsequent disclosures.
AI-generated from 4 reports · updated 4 minutes ago
Latest turnChinese brain-computer interface startup Naohu Technology has closed a RMB 700 million Series B led by Guotou Juli, Shenzhen Capital Group and Qinzhi Capital, according to Wallstreetcn. The money will fund multi-center registrational trials and approval of its fully implanted, fully wireless BCI system, a high-volume factory, next-generation products and BCI-AI integration. The company says it has completed 65 clinical trial cases so far.
- Heat index
- 291
- All sources
- 3
- All reports
- 4
- First seen
- 4 hours ago
Reports on this story headlines open the original
Chinese brain-computer interface startup Naohu Technology has closed a RMB 700 million Series B led by Guotou Juli, Shenzhen Capital Group and Qinzhi Capital, according to Wallstreetcn. The money will fund multi-center registrational trials and approval of its fully implanted, fully wireless BCI system, a high-volume factory, next-generation products and BCI-AI integration. The company says it has completed 65 clinical trial cases so far.
华尔街见闻AI score 56SK hynix announced a shareholder return plan worth about $75 billion, including at least KRW 30 trillion in cash dividends and KRW 60 trillion in buybacks and cancellations, Reuters reported. AI infrastructure demand helped lift third-quarter operating profit to KRW 83.3 trillion, more than seven times a year earlier, with revenue up 328% year on year. The company says DRAM and HBM capacity is booked through 2029 and shortages may last until 2030.
IT之家AI score 71SK hynix CEO Kwak Noh-jung said at the company's earnings call that DRAM and HBM capacity is effectively sold out for the next three years through 2029, counting signed long-term agreements plus demand still under negotiation, Caixin reported. He said the orders being discussed are backed by customers' firm procurement plans and are highly likely to materialize, sharply improving long-term sales visibility.
36氪AI score 61According to IT Home, Chinese brain-computer interface startup NeuroXess has raised RMB 700 million in Series B funding led by SDIC Juyi, Shenzhen Capital Group and QinZhi Capital. The company plans to use the funds for multi-center clinical trials and regulatory approval of its fully implantable, wireless, full-function BCI system, mass-production facilities, and BCI-AI integration research. NeuroXess aims to bring its product to scaled clinical use within two years.
IT之家AI score 63
Other stories people are talking about
- Heat index 1796RisingAnthropic files IPO application, discloses financials and AI risks26 sources
- Heat index 1279SurgeGoogle DeepMind releases Genie 4, a real-time interactive world model16 sources
- Heat index 1090Meta's $25B Stock Offering Oversubscribed 5x at $625 per Share19 sources
- Heat index 1032OpenAI publishes GPT-6.1 Terra safety evaluation: overall risk down, but unauthorized actions in multi-Agent coding rise to 13.75%21 sources
- Heat index 737RisingOpenAI's selective release of three results draws researcher backlash, Anthropic counters11 sources
How is heat calculated?About the methodHide
Heat counts how many independent sources covered a story in the last 48 hours: one source counts once no matter how many posts it published, decaying with a 24-hour half-life. What ranks first is what many people are talking about.
This page aggregates public feeds. Headlines and summaries are machine-organized and remain the property of the original authors; verify important facts at the source. If you believe a headline or summary infringes your rights, email the contact address in the footer with the page URL and basis of your claim, and we will remove or replace it after review.
- Surge
- Discussion rising fast
- New
- First report within 6 hours
- Rising
- Still gathering discussion